Cargando…

Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience

INTRODUCTION: The solid pseudopapillary epithelial neoplasm (SPN) is a rare form of pancreatic neoplasm with an incidence of 2-3% of all pancreatic tumours. The recent increase in incidence is attributed to the increasing use of imaging techniques for nonspecific abdominal complaints. We report our...

Descripción completa

Detalles Bibliográficos
Autores principales: Jena, Suvendu Sekhar, Ray, Samrat, Das, Sri Aurobindo Prasad, Mehta, Naimish N, Yadav, Amitabh, Nundy, Samiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463183/
https://www.ncbi.nlm.nih.gov/pubmed/34568545
http://dx.doi.org/10.1155/2021/7377991
_version_ 1784572345119145984
author Jena, Suvendu Sekhar
Ray, Samrat
Das, Sri Aurobindo Prasad
Mehta, Naimish N
Yadav, Amitabh
Nundy, Samiran
author_facet Jena, Suvendu Sekhar
Ray, Samrat
Das, Sri Aurobindo Prasad
Mehta, Naimish N
Yadav, Amitabh
Nundy, Samiran
author_sort Jena, Suvendu Sekhar
collection PubMed
description INTRODUCTION: The solid pseudopapillary epithelial neoplasm (SPN) is a rare form of pancreatic neoplasm with an incidence of 2-3% of all pancreatic tumours. The recent increase in incidence is attributed to the increasing use of imaging techniques for nonspecific abdominal complaints. We report our institutional experience in the management of this tumour over the last decade. METHOD: We retrospectively analyzed from a prospectively maintained database of patients from January 2011 to December 2020 who were operated upon for SPN. All the patients were followed till date. RESULTS: Of 479 patients operated on for various types of pancreatic tumours during this period, 15 (3.1%) had SPN. The mean age of presentation was 28 years with a female preponderance (12/15, 80%). The most common location was the body and tail of the pancreas (66%), and the mean size was 6.4 cm (2–15 cm). The tumour extent was defined as ‘borderline resectable' in 20% of cases. Distal pancreatectomy was done in 11 patients with spleen preservation in 3. R0, R1, and R2 resection were done in 12, 2, and 1 patient(s), respectively. The operative mortality was 6.7%. All the patients are doing well on follow-up. CONCLUSION: SPN is a low-grade malignant tumour with a strong female predilection. Clinical manifestations have no specificity, imaging examination only contributes tumour location, and the final diagnosis rests on pathology. Surgery is the main modality of treatment and carries a good prognosis.
format Online
Article
Text
id pubmed-8463183
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84631832021-09-25 Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience Jena, Suvendu Sekhar Ray, Samrat Das, Sri Aurobindo Prasad Mehta, Naimish N Yadav, Amitabh Nundy, Samiran Surg Res Pract Research Article INTRODUCTION: The solid pseudopapillary epithelial neoplasm (SPN) is a rare form of pancreatic neoplasm with an incidence of 2-3% of all pancreatic tumours. The recent increase in incidence is attributed to the increasing use of imaging techniques for nonspecific abdominal complaints. We report our institutional experience in the management of this tumour over the last decade. METHOD: We retrospectively analyzed from a prospectively maintained database of patients from January 2011 to December 2020 who were operated upon for SPN. All the patients were followed till date. RESULTS: Of 479 patients operated on for various types of pancreatic tumours during this period, 15 (3.1%) had SPN. The mean age of presentation was 28 years with a female preponderance (12/15, 80%). The most common location was the body and tail of the pancreas (66%), and the mean size was 6.4 cm (2–15 cm). The tumour extent was defined as ‘borderline resectable' in 20% of cases. Distal pancreatectomy was done in 11 patients with spleen preservation in 3. R0, R1, and R2 resection were done in 12, 2, and 1 patient(s), respectively. The operative mortality was 6.7%. All the patients are doing well on follow-up. CONCLUSION: SPN is a low-grade malignant tumour with a strong female predilection. Clinical manifestations have no specificity, imaging examination only contributes tumour location, and the final diagnosis rests on pathology. Surgery is the main modality of treatment and carries a good prognosis. Hindawi 2021-09-17 /pmc/articles/PMC8463183/ /pubmed/34568545 http://dx.doi.org/10.1155/2021/7377991 Text en Copyright © 2021 Suvendu Sekhar Jena et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jena, Suvendu Sekhar
Ray, Samrat
Das, Sri Aurobindo Prasad
Mehta, Naimish N
Yadav, Amitabh
Nundy, Samiran
Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title_full Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title_fullStr Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title_full_unstemmed Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title_short Rare Pseudopapillary Neoplasm of the Pancreas: A 10-Year Experience
title_sort rare pseudopapillary neoplasm of the pancreas: a 10-year experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463183/
https://www.ncbi.nlm.nih.gov/pubmed/34568545
http://dx.doi.org/10.1155/2021/7377991
work_keys_str_mv AT jenasuvendusekhar rarepseudopapillaryneoplasmofthepancreasa10yearexperience
AT raysamrat rarepseudopapillaryneoplasmofthepancreasa10yearexperience
AT dassriaurobindoprasad rarepseudopapillaryneoplasmofthepancreasa10yearexperience
AT mehtanaimishn rarepseudopapillaryneoplasmofthepancreasa10yearexperience
AT yadavamitabh rarepseudopapillaryneoplasmofthepancreasa10yearexperience
AT nundysamiran rarepseudopapillaryneoplasmofthepancreasa10yearexperience